Progenics Pharmaceuticals, Inc. drugs

1 result
  • pylarify - piflufolastat f-18 injection

    (Piflufolastat F-18)
    Progenics Pharmaceuticals, Inc.
    PYLARIFY is a PET imaging agent used to detect PSMA-positive prostate cancer lesions in men with suspected metastasis before initial therapy or suspected recurrence indicated by elevated PSA levels.